Breakthrough in Vascular Tissue Engineering
A team of researchers has developed a novel composite material for small-diameter artificial blood vessels using coaxial 3D printing technology. The work, published on November 20, 2026, in Colloids and Surfaces A: Physicochemical and Engineering Aspects, demonstrates significant improvements in mechanical strength, blood compatibility, and endothelial cell support.
The study focuses on small-diameter vessels with inner diameters under 6 mm, a critical area where current synthetic grafts often fail due to thrombosis and poor integration with host tissue. Lead researchers Yuxuan Liu, Ruofeng Yang, Hao Xu, Zongyi Li, Yan Wei, Ziwei Liang, Weimo Han, and Di Huang, affiliated with institutions including Taiyuan University of Technology, combined carboxylated Euglena gracilis polysaccharide with polyvinyl alcohol and sodium alginate.
Addressing Clinical Challenges in Vascular Grafts
Cardiovascular diseases remain a leading global health issue, driving demand for reliable vascular replacements. While large-diameter grafts made from materials like expanded polytetrafluoroethylene perform well clinically, small-diameter options face persistent problems including acute clotting and slow endothelialization. The new composite addresses these by leveraging the bioactivity of the modified polysaccharide to create a more biomimetic scaffold.
The fabrication process employs coaxial extrusion 3D printing, allowing precise control over tubular structures. A dual-crosslinking approach involving ionic agents and repeated freeze-thaw cycles produces hierarchical networks that enhance both durability and biological performance.
Material Composition and Fabrication Details
The bioink consists of polyvinyl alcohol and sodium alginate as the base, enhanced with varying concentrations of carboxylated Euglena gracilis polysaccharide. This polysaccharide, derived from the microalga Euglena gracilis and modified through carboxymethylation, introduces negative charges that help repel platelets while promoting cell adhesion.
Printing parameters include an outer nozzle diameter of 3.5 mm and inner diameter of 2.8 mm, with controlled extrusion speeds and a crosslinking bath containing calcium chloride and boric acid. Post-printing freeze-thaw cycles further stabilize the structure.
Mechanical Performance Improvements
Testing revealed notable gains in mechanical properties. The 1% CEGP composite achieved an elastic modulus of 2.03 MPa, compared to 1.22 MPa for the control without the polysaccharide. Burst pressure reached 264.5 mmHg, meeting clinical standards for small-diameter applications.
These enhancements stem from synergistic hydrogen bonding and ionic interactions within the network, providing better resistance to physiological stresses while maintaining flexibility suitable for vascular environments.
Hemocompatibility and Blood Interaction
Hemocompatibility assessments showed substantial reductions in platelet adhesion. The composite surface limited platelet density to approximately 110,000 per square millimeter, down from nearly 260,000 in controls. The hydrophilic nature and negative charge barrier contribute to this anti-thrombotic effect.
Perfusion tests confirmed the vessels maintain structural integrity under flow conditions, with no leakage observed over extended periods.
Endothelialization and Cellular Response
In vitro studies using human umbilical vein endothelial cells demonstrated accelerated proliferation and migration. Cell viability remained above 80% at day five, with complete scratch wound closure achieved within two days in migration assays.
The CEGP component appears to actively support endothelial cell behavior, a key factor for long-term graft patency and integration with native vasculature.
Photo by Testalize.me on Unsplash
Implications for Biomedical Engineering
This research offers a promising pathway for developing personalized small-diameter vascular grafts. The coaxial 3D printing method allows customization of dimensions and properties, potentially reducing reliance on autologous vessels and mitigating immune rejection risks associated with allografts.
Future directions may include in vivo testing and scaling production for clinical translation, building on the balanced mechanical and biological performance demonstrated here.
Broader Context in Tissue Engineering
The work aligns with ongoing advances in additive manufacturing for regenerative medicine. By integrating natural bioactive polysaccharides with established synthetic polymers, the approach bridges gaps in current vascular scaffold technologies.
Researchers continue to explore similar composite strategies for other tissue applications, emphasizing the role of material modification in overcoming longstanding barriers to clinical adoption.